Professional
Added to YB: 2024-04-15
Pitch date: 2024-03-31
IQV [bullish]
IQVIA Holdings Inc.
-11.72%
current return
Author Info
No bio for this author
Company Info
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Market Cap
$38.5B
Pitch Price
$253.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.87
P/E
30.92
EV/Sales
3.26
Sector
Life Sciences Tools and Services
Category
value
Oakmark Global Select Fund New Position: IQVIA Holdings Inc.
IQV: Attractive entry on biotech funding fears. Decentralized trials, data & software enable growth from personalized medicine trend & real-world evidence needs. CEO Bousbib's strong track record & skin in the game via large equity stake. Purchased at discount to intrinsic value estimate.
Read full article (1 min)